Welcome to our dedicated page for Greenlane Holdings SEC filings (Ticker: GNLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Greenlane Holdings, Inc. (GNLN) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, including current reports, proxy materials, and periodic filings. Greenlane’s filings document its evolution from a wholesale distributor of premium smoking accessories, vape devices, lifestyle products, child-resistant packaging, and specialty vaporization products into a Berachain-focused digital asset treasury company.
Investors reviewing Greenlane’s Forms 8-K can see detailed information on material events such as the adoption of a Berachain cryptocurrency treasury strategy centered on the BERA token, the closing of a significant private placement involving cash, stablecoins, and BERA, the establishment of a Digital Assets Committee, and the appointment of a Chief Investment Officer to manage the BERA treasury. Other 8-K filings describe changes in directors and officers, reverse stock split approvals and implementation, Nasdaq compliance matters, and key governance decisions.
The company’s definitive proxy statement on Schedule 14A outlines proposals presented to stockholders, including board elections, auditor ratification, amendments to the 2019 Equity Incentive Plan, and approvals related to the private placement and advisory warrants. Quarterly and annual reports, referenced in Greenlane’s news releases, provide financial statements and management discussion of its distribution business, restructuring efforts, and transition toward a capital-light, IP-driven operating model alongside its digital asset activities.
On Stock Titan, these filings are paired with AI-powered summaries designed to help readers interpret complex documents such as 10-K annual reports, 10-Q quarterly reports, and 8-K current reports. Users can also monitor equity incentive plan amendments and other governance-related disclosures. For a comprehensive view of GNLN’s regulatory history and its shift toward a Berachain-focused treasury strategy, this page consolidates Greenlane’s key SEC filings in one place.
Altium Capital Management LLC, Altium Healthcare Long Short Onshore Fund LP and Altium Healthcare Long Short GP LLC jointly report beneficial ownership related to Greenlane Holdings, Inc. common stock (CUSIP 395330509). The filing shows 21,008 shares of common stock that would be issuable upon full conversion/exercise of Series A Warrants, representing 0.12% of the class based on 17,394,226 shares outstanding as reported by the issuer. The reported counts do not give effect to a 4.99% Warrant Blocker, which prevents the Reporting Persons from exercising warrants if doing so would increase their ownership above 4.99%, so the actual post-blocker ownership is lower than reported.
The filing discloses that the Fund is the direct record owner and that Altium Capital Management LLC and Altium Healthcare Long Short GP LLC may be deemed to beneficially own the securities due to advisory and general partner roles. The parties certify the securities were not acquired to change or influence control of the issuer.
Greenlane Holdings, Inc. Schedule 13G/A reports that Ayrton Capital LLC, Alto Opportunity Master Fund (Segregated Master Portfolio B) and Waqas Khatri collectively hold economic and voting power over 14,028 shares of common stock, representing 1.02% of the class. The reported position consists of common stock issuable upon exercise of warrants held by the reporting persons and is subject to a 9.99% beneficial ownership blocker. The percentage calculation is based on 1,360,835 shares outstanding reported by the issuer, and the holdings are reported as of June 30, 2025. The filing identifies the reporting parties, their jurisdictions, and confirms sole voting and dispositive power over the 14,028 shares.
Greenlane Holdings (Nasdaq:GNLN) filed an 8-K reporting the June 20, 2025 termination of Chief Growth Officer Rob Shields under Item 5.02 (Departure of Certain Officers). The filing provides no reason for the dismissal and discloses no severance, succession plan, or compensatory arrangements. There are no accompanying financial statements or forward-looking updates, making the leadership change the sole material event investors must evaluate.
Greenlane Holdings (NASDAQ: GNLN) has filed an amended 8-K to correct information regarding a Nasdaq compliance extension. The company received notice from Nasdaq on May 30, 2025, granting an extension until July 11, 2025 to regain compliance with the minimum bid price requirement under Listing Rule 5550(a)(2).
This amendment specifically corrects the extension date reported in the original 8-K filed on June 2, 2025. The company faces delisting risk if unable to meet the minimum bid price requirement by the deadline. Management states they will actively monitor the bid price and take necessary steps to regain compliance within the extended period.
- Trading Status: Listed on Nasdaq Capital Market
- Security: Class A Common Stock ($0.01 par value)
- Compliance Issue: Minimum bid price requirement
- Extension Deadline: July 11, 2025